Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Avacopan may cause unexpected side effects, so early monitoring is important.

Low-intensity ultrasound can safely enhance hair regrowth by selecting the right frequency and intensity.

Dupilumab helps children with alopecia areata regrow hair safely.

The gene for Marie Unna hereditary hypotrichosis is located on chromosome 8p21, near the hairless gene.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

PRP, especially AA-PRP, can help improve hair growth in androgenetic alopecia.

Amla is a nutritious fruit with many health benefits, including improving digestion, heart health, and hair growth.

A new gene mutation linked to a skin condition was found in a Spanish family.

A different gene near the hairless gene on chromosome 8p21 causes a rare hair loss condition in a German family.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Recent selection on immune response genes was identified across seven ethnicities.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Alopecia causes sudden hair loss, possibly due to genetic, environmental, or immune factors.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

UVA exposure worsens hair loss by activating a specific cell pathway.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Hutchinson-Gilford Progeria Syndrome is a rare genetic disorder caused by a specific gene mutation, characterized by aging symptoms and managed by monitoring heart health and using low-dose aspirin.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Early-onset alopecia, especially with a family history, leads to worse outcomes and more related health issues.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.